Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular profiling of ER plus metastatic breast cancers to reveal association of genomic alterations with acquired resistance to CDK4/6 inhibitors
    Meeting Abstract

    Razavi, P.; dos Anjos, C. H.; Brown, D. N.; Qing, L.; Ping, C.; Herbert, J.; Colon, J.; Liu, D.; Mao, M.; Norton, L.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Exercise trends among previously non-exercising breast cancer survivors: Analysis of an ethnically diverse sample
    Meeting Abstract

    Oza, S.; Blinder, V. S.; Tran, C.; Patil, S.; Gany, F.; Roberts, N.; Kampel, L. J.; Malik, M.; Bao, T.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase II study of dual immune checkpoint blockade (ICB) plus androgen receptor (AR) blockade to enhance thymic T-cell production and immunotherapy response in metastatic breast cancer (MBC)
    Meeting Abstract

    Page, D. B.; Kim, I. K.; Chun, B.; Redmond, W. L.; Martel, M.; Mori, M.; Wadell, D.; Moxon, N.; Mellinger, S. L.; Urba, W. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • CONTESSA: A multinational, multicenter, randomized, phase III registration study of tesetaxel plus a reduced dose of capecitabine in patients (pts) with HER2-, hormone receptor plus (HR plus ) locally advanced or metastatic breast cancer (LA/MBC) who have previously received a taxane
    Meeting Abstract

    O'Shaughnessy, J.; Piccart, M.; Schwartzberg, L. S.; Cortes, J.; Harbeck, N.; Im, S. A.; Rugo, H. S.; Untch, M.; Yardley, D. A.; Bondarenko, I.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Early results from the BRCA Founder Outreach (BFOR) Study: Population genetic screening using a medical model
    Meeting Abstract

    Morgan, K.; Gabriel, C.; Symecko, H.; Lester, J.; Levin, J.; Kamara, D.; Spielman, K.; Jenkins, C.; Hamilton, J. G.; Fesko, Y. A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase III, multicenter, randomized, open label trial of [fam-] trastuzumab deruxtecan (DS-8201a) versus investigator's choice in HER2-low breast cancer
    Meeting Abstract

    Modi, S.; Ohtani, S.; Lee, C. C.; Wang, K.; Saxena, K.; Cameron, D. A.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Breast radiotherapy among ATM-mutation carriers
    Meeting Abstract

    Modlin, L. A.; Flynn, J.; Zhang, Z.; Mueller, B.; Khan, A. J.; Gillespie, E. F.; Cahlon, O.; McCormick, B.; Robson, M. E.; Powell, S. N.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Biomarker predictors of outcome from a randomized trial of nivolumab +/- stereotactic body radiotherapy (SBRT) in metastatic (M1) head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    McBride, S. M.; Lee, N. Y.; Pfister, D. G.; Sherman, E. J.; Tsai, C. J.; Aghalar, J.; Eng, J.; Zhi, W. I.; McFarland, D. C.; Michel, L. S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • TBCRC 030: A randomized phase II study of preoperative cisplatin versus paclitaxel in TNBC-Evaluating the homologous recombination deficiency (HRD) biomarker
    Meeting Abstract

    Mayer, E. L.; Abramson, V. G.; Jankowitz, R. C.; Falkson, C. I.; Marcom, P. K.; Traina, T. A.; Carey, L. A.; Rimawi, M. F.; Specht, J. M.; Miller, K.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Acupuncture versus cognitive behavioral therapy for cognitive impairment in cancer survivors with insomnia: Implications for personalized medicine
    Meeting Abstract

    Mao, J. J.; Liou, K.; Root, J.; Li, Q. S.; Bao, T.; Garland, S. N.; Ahles, T.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save